- Institucional
- Equipe
- Pesquisa
- Áreas de Atuação
- Bolsas (editais abertos)
- BOLSA FAPESP DE TT-II em CancerThera – Biologia Molecular e Farmácia – Braço Básico
- BOLSA FAPESP DE TT-III em CancerThera – Medicina Nuclear, Radiofarmácia e Radioquímica – Braço Clínico
- BOLSA FAPESP DE DOUTORADO em CancerThera – Medicina Nuclear – Braço Clínico
- BOLSA FAPESP DE PÓS-DOUTORADO em CancerThera – Medicina Nuclear – Braço Clínico
- Equipamentos Multiusuários
- Inovação
- Difusão
![](https://www.cancerthera.org.br/wp-content/uploads/2023/09/CANCERTHERA-homepage-imagens-de-entrada-1d.jpg)
![](https://www.cancerthera.org.br/wp-content/uploads/2023/08/CANCERTHERA-homepage-imagens-de-entrada-4.jpg)
![](https://www.cancerthera.org.br/wp-content/uploads/2023/08/CANCERTHERA-homepage-imagens-de-entrada-2.jpg)
![](https://www.cancerthera.org.br/wp-content/uploads/2023/09/CANCERTHERA-homepage-imagens-de-entrada-Congresso-3.jpg)
AREAS OF EXPERTISE
Learn details about CancerThera RIDC´s areas of expertise
- WHAT IS CANCERTHERA?
Cancer is a significant global public health problem and is among the leading causes of death. Identifying new agents for the diagnosis and treatment of patients with tumors is highly desirable. For many centuries, metals have been used empirically to treat various diseases. Currently, metals and their compounds - stable or radioactive - are applied rationally in neoplasms. This is the area in which we operate.
About the RIDC
The "Center for Cancer Theranostic Innovation" will develop research, innovation, and knowledge dissemination activities for the creation of new drugs and metal-based radiopharmaceuticals for the diagnosis and treatment of cancer. It will also study new uses for known radiopharmaceuticals, adopting an innovative model in the country, to become a world-class center for cancer research.